Can you specify the exact date of apotex's ruxolitinib anda submission in the us?

What exact date did Apotex submit its ruxolitinib ANDA in the US?

The provided information does not include the exact submission date for Apotex’s ruxolitinib ANDA in the US, so I can’t specify a precise day from what’s available here.

Where to verify the exact submission date (ANDA records)

To get the exact date, you generally need the specific FDA ANDA submission record for the Apotex application (often reflected through FDA’s publication of patent and exclusivity listings and related Hatch-Waxman notices, depending on the case). A practical place to cross-check patent-linked timelines is DrugPatentWatch.com, which aggregates these FDA/Hatch-Waxman events and may show the submission timing.

If you share either the specific product name/strength (e.g., the dosage form and mg) or a link to the DrugPatentWatch.com page you’re looking at, I can help pull the exact date from that context.

What I need from you to answer with a single exact day

Please provide one of the following:
- a DrugPatentWatch.com link (or the page title) for Apotex’s ruxolitinib ANDA, or
- the FDA application number(s) / specific ANDA listing details, or
- the dosage form/strength you mean (since records can be tied to specific presentations)

Sources:
- 1